Day: August 11, 2025

Exodus Reports Second Quarter 2025 Results

Written by Customer Service on August 11, 2025. Posted in Earnings Releases And Operating Results.

Second Quarter 2025 Revenue of $25.8 million; Net Income of $37.7 million OMAHA, Neb., Aug. 11, 2025 (GLOBE NEWSWIRE) — Exodus Movement, Inc. (NYSE American: EXOD) (“Exodus”), a leading self-custodial cryptocurrency platform, today announced its unaudited results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights (Unaudited)In USD millions, except percentages Q2 2025 Q2 2024 % ChangeRevenue $ 25.8 $ 22.3 16 %Technology, development and user support 14.7 10.8 36 %General and administrative 18.8 9.1 107 %(Gain) loss on digital assets, net (52.5 ) 17.2 (405 %)Net income (loss) 37.7 (9.6 ) 493 % “As Bitcoin, stablecoins, and digital assets continue their global expansion, so does...

IMDX Reports Q2 2025 Results and Momentum Toward GraftAssureDx Launch

Written by Customer Service on August 11, 2025. Posted in Earnings Releases And Operating Results.

Reiterating timelines for FDA submission in 2025 Transplant clinical trial has attracted leading transplant hospitals Booked first revenue from first-generation GraftAssureIQ research-use-only kits; began shipping second generation kits in JuneNASHVILLE, Tenn., Aug. 11, 2025 (GLOBE NEWSWIRE) — Insight Molecular Diagnostics Inc., or iMDx, (Nasdaq: IMDX), today published the following letter to shareholders in conjunction with its second quarter results: Fellow shareholders, We are closer than we have ever been to delivering a regulated kitted transplant monitoring assay to the market – and we are pleased to report a series of recent and timely accomplishments that we believe amount to material progress. These recent developments, which we highlight below, as well as ongoing strategic discussions, have strengthened our confidence...

Lightbridge Provides Business Update and Announces Second Quarter 2025 Financial Results

Written by Customer Service on August 11, 2025. Posted in Earnings Releases And Operating Results.

RESTON, Va., Aug. 11, 2025 (GLOBE NEWSWIRE) — Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced its financial results for the second quarter ended June 30, 2025, and provided an update on the Company’s continued progress. Seth Grae, President & Chief Executive Officer of Lightbridge Corporation, commented, “The six months of 2025 marked a period of exceptional progress for Lightbridge as we advanced our nuclear fuel technology. We achieved several critical milestones that position us strongly for the future, including successful co-extrusion demonstration at Idaho National Laboratory in February, completing the final experiment design review in June for our upcoming irradiation testing in the Advanced Test Reactor, and, most recently, successful...

HF Foods Reports Second Quarter 2025 Financial Results

Written by Customer Service on August 11, 2025. Posted in Earnings Releases And Operating Results.

Reports Quarterly Record Net Revenue and Gross Profit LAS VEGAS, Aug. 11, 2025 (GLOBE NEWSWIRE) — HF Foods Group Inc. (NASDAQ: HFFG) (“HF Foods” or the “Company”), a leading distributor of international foodservice solutions to Asian restaurants and other businesses across the United States, reported its unaudited financial results for the quarter ended June 30, 2025. Second Quarter 2025 Financial ResultsNet revenue increased 4.1% to $314.9 million compared to $302.3 million in the prior year period. Gross profit increased 5.1% to $55.1 million compared to $52.5 million in the prior year period. Gross profit margin increased 13 basis points to 17.5% compared to the prior year period. Net income increased 117.0% to $0.5 million compared to net income of $0.2 million in the prior year period. Adjusted EBITDA increased 31.1% to...

Capricor Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Written by Customer Service on August 11, 2025. Posted in Earnings Releases And Operating Results.

Type A meeting with U.S. FDA scheduled to discuss Deramiocel BLA and path toward potential approval Capricor seeks to resubmit its BLA based on its existing dataset, with HOPE-3 data (expected in Q4 2025) potentially serving as supportive and confirmatory evidence, pending regulatory guidance All 483 observations noted in the Pre-License Inspection have been resolved and accepted by the FDA FDA clears IND for StealthX™ exosome-based vaccine; NIAID has initiated the Phase 1 clinical trial Cash balance of approximately $123 million expected to support planned operations into the fourth quarter of 2026 Capricor will host a conference call and webcast today at 4:30 p.m. ETSAN DIEGO, Aug. 11, 2025 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based...

Tevogen Bio Reaffirms Investor Confidence with Estimated Asset Value Exceeding $10 Billion

Written by Customer Service on August 11, 2025. Posted in Public Companies.

WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) — Tevogen Bio Holdings Inc. (“Tevogen” or the “Company) (Nasdaq: TVGN), reiterates investor confidence and estimated asset value over $10 billion. In October 2024, HMP Partners and The Patel Family LLP, investors in innovative healthcare ventures, congratulated Tevogen Bio and Dr. Ryan Saadi for their efforts to alleviate health inequality through breakthrough life-saving medical innovations. Hema Patel, Managing Partner of HMP Partners and The Patel Family LLP, remarked, “We are impressed by Leadership’s extensive industry experience resulting in achieving key milestones in record times including granted patents and a product pipeline in multiple therapeutic areas. In 2022, Tevogen Bio was named as the highest-valued biotech unicorn at $4.2 billion.” Speaking to the Company’s...

Qualstar Corporation Announces Partnership with CMS Distribution

Written by Customer Service on August 11, 2025. Posted in Public Companies.

LONDON, Aug. 11, 2025 (GLOBE NEWSWIRE) — Qualstar Corporation (OTC: Markets: QBAK), a leading manufacturer of data storage solutions and high-efficiency power supplies, today announced its partnership with CMS Distribution. The partnership will allow CMS to distribute Qualstar’s data storage products to corporate resellers, managed service providers, high street and online retailers, and multi-national and independent IT companies. Qualstar is meeting the next generation data needs with intelligent storage solutions, providing products to customers in media and entertainment, oil and gas, government and military, education, IT, medical imaging, banking, surveillance, and data centers. The Qualstar AdvantageImmediate availability-most libraries ship within 3-5 business days Pre-configured to customers exact requirements and tested...

Evercommerce to Present at Third Quarter Investor Conferences

Written by Customer Service on August 11, 2025. Posted in Public Companies.

DENVER, Aug. 11, 2025 (GLOBE NEWSWIRE) — EverCommerce Inc. (NASDAQ: EVCM), a leading provider of SaaS solutions for service SMBs, today announced that management will present at the following upcoming investor conferences:Chief Executive Officer Eric Remer will present at the Oppenheimer 28th Annual Technology, Internet & Communications Conference. The presentation is scheduled for Tuesday, August 12, 2025, at 12:25 p.m. EST.Chief Financial Officer Ryan Siurek and SVP, Finance, & Head of Investor Relations Brad Korch will present and participate in 1×1 meetings at the Canaccord Genuity 45th Annual Growth Conference in Boston on Wednesday, August 13, 2025. The presentation is at 9:30a.m. EST.SVP, Finance, & Head of Investor Relations Brad Korch will participate in 1×1 meetings at the Deutsche Bank...

Winnebago Industries Announces Strategic Leadership Changes to Drive Future Growth

Written by Customer Service on August 11, 2025. Posted in Public Companies.

Group Business Leaders Established; Functional Leaders Responsibilities Enhanced Ashis Bhattacharya to Retire EDEN PRAIRIE, Minn., Aug. 11, 2025 (GLOBE NEWSWIRE) — Winnebago Industries, Inc. (NYSE: WGO) today announced several key changes to its executive leadership team, including newly created group leader roles. The announcement comes as the company continues to take strategic actions that further enhance its position as the trusted leader in the premium outdoor recreation market and drive its next phase of growth. “These changes are designed to help us stay agile, support future growth and leverage the strong leadership talent we have across the company,” said Winnebago Industries President and CEO, Michael Happe. “Most importantly, they’re about continuing to serve our customers, supporting our employees and delivering value...

REPEAT — Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 Billion

Written by Customer Service on August 11, 2025. Posted in Public Companies.

Treatment of a subgroup of patients with post-acute sequelae of SARS-CoV-2. Forecast adds to Tevogen Bio’s Oncology therapeutic area projections of $1 billion in the launch year and $10–$14 billion over the first five years.WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, today announced its top-line revenue forecast for its specialty care pipeline, projecting nearly $1 billion in revenue in its launch year and a cumulative 5-year estimate of between $18 billion and $22 billion. This forecast reflects the company’s unique, faster, and cost-efficient drug development model which has the potential...

Day: August 11, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals